Carcinogenesis, cancer therapy and chemoprevention

被引：81

作者：

Blagosklonny, MV ^{[1
]}

机构：

[1] New York Med Coll, Brander Canc Res Inst, Hawthorne, NY 10532 USA

来源：

CELL DEATH AND DIFFERENTIATION | 2005年 / 12卷 / 06期

关键词：

carcinogenesis; cancer therapy; chemoprevention;

D O I：

10.1038/sj.cdd.4401610

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Carcinogenesis and cancer therapy are two sides of the same coin, such that the same cytotoxic agent can cause cancer and be used to treat cancer. This review links carcinogenesis, chemoprevention and cancer therapy in one process driven by cytotoxic agents (carcinoagents) that select either for or against cells with oncogenic alterations. By unifying therapy and cancer promotion and by distinguishing nononcogenic and oncogenic mechanisms of resistance, I discuss anticancer- and chemopreventive agent-induced carcinogenesis and tumor progression and, vice versa, carcinogens as anticancer drugs, anticancer drugs as chemopreventive agents and exploiting oncogene-addiction and drug resistance for chemoprevention and cancer therapy.

引用

页码：592 / 602

页数：11

共 155 条

[51] Percutaneous alcohol ablation for liver metastasis
Giovannini, M
[J]. SEMINARS IN ONCOLOGY, 2002, 29 (02) : 192 - 195
[52] How Cancers Escape Their Oncogene Habit
Giuriato, Sylvie
Felsher, Dean W.
[J]. CELL CYCLE, 2003, 2 (04) : 329 - 332
[53] A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin
Glynn, SA
Gammell, P
Heenan, M
O'Connor, R
Liang, Y
Keenan, J
Clynes, M
[J]. BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1800 - 1807
[54] A matter of life and death
Green, DR
Evan, GI
[J]. CANCER CELL, 2002, 1 (01) : 19 - 30
[55] Greenhalgh DA, 1996, CANCER RES, V56, P4413
[56] Guo N, 2002, CELL GROWTH DIFFER, V13, P77
[57] The influence of carcinogenic substances on sarcomata induced by the same and other compounds
Haddow, A
[J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1938, 47 (03): : 581 - 591
[58] Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: Preliminary studies on therapeutic efficacy and toxicity
Han, ZT
Zhu, XX
Yang, RY
Sun, JZ
Tian, GF
Liu, XJ
Cao, GS
Newmark, HL
Conney, AH
Chang, RL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 5357 - 5361
[59] 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced increase in depressed white blood cell counts in patients treated with cytotoxic cancer chemotherapeutic drugs
Han, ZT
Tong, YK
He, LM
Zhang, Y
Sun, JZ
Wang, TY
Zhang, H
Cui, YL
Newmark, HL
Conney, AH
Chang, RL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 5362 - 5365
[60] The hallmarks of cancer
Hanahan, D
Weinberg, RA
[J]. CELL, 2000, 100 (01) : 57 - 70

← 1 2 3 4 5 6 7 8 9 10 →